Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of L-carnitine infusion on lipid-induced insulin resistance
2016-000810-31Phase 4Terminated
- Sponsor
- Maastricht University
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of levocarnitine in insulin resistance (IR) and prediabetes, sponsored by Maastricht University. Primary endpoint: Whole body insulin sensitivity. Started Mar 2016; status: terminated.
02
Drugs
levocarnitine
03
Conditions
insulin resistance (IR)prediabetes
Beyond the preview
Go deeper on 2016-000810-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000810-31.